Minghui scientists divulge new IGF-1R-targeting antibody-drug conjugates
June 20, 2024
Scientists at Minghui Pharmaceutical (Hangzhou) Ltd. and Minghui Pharmaceutical Inc. have synthesized antibody-drug conjugates comprising a humanized monoclonal antibody targeting insulin-like growth factor 1 receptor (IGF-1R) linked to a cytotoxic drug through a linker and reported to be useful for the treatment of cancer.